Five Years In, CAR-T Lupus Patients Remain in Drug-Free Remission

The first lupus patient treated with CD19 CAR-T cells in 2021 at University Hospital Erlangen remains in complete remission. Across expanding trials, most of dozens of patients have sustained drug-free responses, validating a paradigm shift from chronic immunosuppression to one-time cellular reset.

By BT Research